SHIRE HUMAN GENETIC THERAPIES H-1B Visa Sponsorship & Salary Data

The median H-1B salary at SHIRE HUMAN GENETIC THERAPIES is $125,000, based on 110 certified filings from FY 2020 to FY 2026. This is 4% higher than the national H-1B median salary of $120,000. Compensation at SHIRE HUMAN GENETIC THERAPIES reflects their market positioning, with entry-level roles starting around $104,000 and senior positions reaching $180,250 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at SHIRE HUMAN GENETIC THERAPIES range from $85,000 at the 10th percentile to $180,250 at the 90th percentile, showing a $95,250 spread across experience levels and roles. The 25th percentile is $104,000 and the 75th percentile is $152,193.

Yes, SHIRE HUMAN GENETIC THERAPIES actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 115 H-1B labor condition applications from FY 2020 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 110 certified applications and a 0% denial rate, SHIRE HUMAN GENETIC THERAPIES maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), SHIRE HUMAN GENETIC THERAPIES filed 1 H-1B applications, with 1 certified and 0 denied. Over 7 years of data, SHIRE HUMAN GENETIC THERAPIES has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

SHIRE HUMAN GENETIC THERAPIES's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 115 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating SHIRE HUMAN GENETIC THERAPIES as a potential H-1B sponsor.

This is an excellent approval rate, indicating SHIRE HUMAN GENETIC THERAPIES has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

SHIRE HUMAN GENETIC THERAPIES sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 110 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles SHIRE HUMAN GENETIC THERAPIES most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at SHIRE HUMAN GENETIC THERAPIES:

The most frequently sponsored role is Senior Validation Engineer with 4 filings at a median salary of $120,000. This is followed by Research Scientist (3 filings) and Project Manager.

SHIRE HUMAN GENETIC THERAPIES's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where SHIRE HUMAN GENETIC THERAPIES sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top SHIRE HUMAN GENETIC THERAPIES H-1B locations:

The largest H-1B hub for SHIRE HUMAN GENETIC THERAPIES is Lexington, MA with 80 filings at a median salary of $120,422. The highest-paying location is Leexington, MA at $176,105 median. Salaries range from $62,000 to $176,105 across office locations.

SHIRE HUMAN GENETIC THERAPIES's median H-1B salary has increased by +46% from FY 2020 ($116,000) to FY 2026 ($169,914). Tracking salary trends over time reveals how SHIRE HUMAN GENETIC THERAPIES adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at SHIRE HUMAN GENETIC THERAPIES.

Year-by-year breakdown:

• FY 2022: $125,000 (14 certified)
• FY 2023: $154,295 (6 certified)
• FY 2024: $130,000 (17 certified)
• FY 2025: $147,733 (5 certified)
• FY 2026: $169,914 (1 certified)

This 46% growth reflects strong compensation adjustments at SHIRE HUMAN GENETIC THERAPIES, keeping pace with market demands for H-1B talent.

SHIRE HUMAN GENETIC THERAPIES primarily files H-1B applications at Wage Level IV, accounting for 42% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making SHIRE HUMAN GENETIC THERAPIES's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 84% of positions at Level II or higher, SHIRE HUMAN GENETIC THERAPIES typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

SHIRE HUMAN GENETIC THERAPIES's median H-1B salary of $125,000 is 4% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating SHIRE HUMAN GENETIC THERAPIES's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare SHIRE HUMAN GENETIC THERAPIES's offerings with similar companies in your field for a more accurate assessment.

SHIRE HUMAN GENETIC THERAPIES offers above-average H-1B compensation. Combined with their 110 certified filings and 0% denial rate, they demonstrate solid H-1B sponsorship practices.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. SHIRE HUMAN GENETIC THERAPIES's higher proportion of Level III-IV positions (57%) may benefit from wage-based lottery prioritization.

With 110 certified filings, SHIRE HUMAN GENETIC THERAPIES invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.